Johan Askling

Karolinska University Hospital — Sweden

Medicine · Health Sciences

93h-index30.2kcitations629works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(310), Systemic Lupus Erythematosus Research(98), Lymphoma Diagnosis and Treatment(96), Spondyloarthritis Studies and Treatments(95), Chronic Lymphocytic Leukemia Research(86)

Publications626 total

Maternal rheumatoid arthritis and the risk of offspring autism spectrum disorder: two national birth cohorts and a meta-analysis
Molecular Autism·2025· 1 citedOpen Access
Matrix metalloproteinase 13 (MMP-13) processing of type II collagen is altered by antibodies and citrullination found in the early stages of rheumatoid arthritis
Matrix Biology·2025· 1 cited
Multiple DMARD discontinuations in rheumatoid arthritis: how often and in what patients? Results from a national clinical RA register
RMD Open·2025Open Access
Letter to the Editor Regarding “Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases”
Rheumatology and Therapy·2025Open Access
Cancer incidence in patients with ulcerative colitis naïve to or treated with thiopurine and targeted therapies—a cohort study 2007 to 2022 with comparison to the general population
Journal of Crohn s and Colitis·2025· 3 citedOpen Access
OP0067 Rheumatoid arthritis, non-TNFi bDMARDs and JAKi - risks of keratinocyte cancer
Annals of the Rheumatic Diseases·2025Open Access
POS1091 Development and Validation of ‘Rheumatic ‘ - A Digital Symptom Checker for Confirmation and Prediction of Rheumatic Diseases: A Large-Scale Prospective Study
Annals of the Rheumatic Diseases·2025Open Access
POS0298 ELEVATED RISK FOR SPECIALISED PSYCHIATRIC CARE DUE TO DEPRESSION OR ANXIETY, BUT NOT FOR SUICIDE, IN A SCANDINAVIAN COHORT OF PATIENTS DIAGNOSED WITH PSORIATIC ARTHRITIS.
Annals of the Rheumatic Diseases·2025Open Access
[SRQ - a solution for quality control, clinical decision support and research in rheumatology].
PubMed·2025
Adult-onset inflammatory bowel disease and the risk of venous thromboembolism – a Swedish nationwide cohort study 2007–2021
Scandinavian Journal of Gastroenterology·2025· 4 citedOpen Access
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With <scp>JAK</scp> Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries
Arthritis & Rheumatology·2025· 12 citedOpen Access
Common genetic variants do not impact clinical prediction of methotrexate treatment outcomes in early rheumatoid arthritis
Journal of Internal Medicine·2025Open Access
In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesity
RMD Open·2025Open Access
Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the <scp>HLA</scp> Class <scp>II</scp> Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid Arthritis
Arthritis & Rheumatology·2025· 4 citedOpen Access
Juvenile Idiopathic Arthritis, Earnings, and Work Loss: A Nationwide Matched Cohort Study
Arthritis Care & Research·2025Open Access
Non‐steroidal anti‐inflammatory drugs and risk of kidney cancer: A Swedish nationwide cohort study in the general and high‐use populations
Journal of Internal Medicine·2025· 1 citedOpen Access
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update
Annals of the Rheumatic Diseases·2025· 16 citedOpen Access
Incidence, stage and outcome of malignant melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?
British Journal of Dermatology·2025· 3 citedOpen Access
Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritis
Annals of the Rheumatic Diseases·2025· 1 citedOpen Access
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
PubMed·2025· 6 citedOpen Access
page 1 of 32Next →

Frequent Co-authors

Lars Klareskog(9), Eva Baecklund(8), Anders Ekbom(8), Anders Ekbom(7), L. Jacobsson(6), Martin Neovius(6), Fredrik Granath(5), Nils Feltelius(5), Jonas F. Ludvigsson(5), Staffan Lindblad(5), Ronald van Vollenhoven(4), Ola Olén(4), Michael C. Sachs(4), Lena Brandt(4), L Cöster(4), Solbritt Rantapää‐Dahlqvist(4), Tore Saxne(4), Kimme L Hyrich(4), Axel Finckh(3), Xavier Mariette(3)